Citation Impact
Citing Papers
Visualization of the HIV-1 Env glycan shield across scales
2020
The frantic play of the concealed HIV envelope cytoplasmic tail
2013
Bell's Palsy Associated with Linezolid Therapy: Case Report and Review of Neuropathic Adverse Events
2006
DNA methylation and the Epstein–Barr virus
1999
Effect of Surface Properties on Nanoparticle–Cell Interactions
2009 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Cytokine mRNA Expression in Mononuclear Cells from Different Tissues during Acute SIVmac251 Infection of Macaques
1996
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus
2009
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Influenza vaccination of health care workers in hospitals—A review of studies on attitudes and predictors
2009
The M1 and M2 paradigm of macrophage activation: time for reassessment
2014 Standout
Exchange Transfusion as an Adjunct Therapy in Severe Plasmodium falciparum Malaria: A Meta‐analysis
2002
Considerations on the use of adjunct red blood cell exchange transfusion in the treatment of severe Plasmodium falciparum malaria
2009
Antiretroviral Therapy for HIV Infection
1998
Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1
1999
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Linezolid for the treatment of adults with bone and joint infections
2007
Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV‐infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks
2005
Exploiting the defensive sugars of HIV-1 for drug and vaccine design
2007 Nature
Humoral immune response in IL‐12 and IFN‐γ deficient mice after infection with Cryptosporidium parvum
2008
Protein and Glycan Mimicry in HIV Vaccine Design
2019
Mycophenolic Acid Inhibits Syncytium Formation Accompanied by Reduction of gp120 Expression
2005 StandoutNobel
Efficacy and tolerance of rifampicin–linezolid compared with rifampicin–cotrimoxazole combinations in prolonged oral therapy for bone and joint infections
2009
Epstein–Barr virus: 40 years on
2004 Standout
Mycophenolate mofetil and its mechanisms of action
2000 Standout
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
1998
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
2006
Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G.
1999
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Early Treatment with Acyclovir for Varicella Pneumonia in Otherwise Healthy Adults: Retrospective Controlled Study and Review
1990
Vaccine hesitancy
2013 Standout
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Septic Arthritis of the Pubic Symphysis
2003
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
1998 Standout
Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: A retrospective study
2006
Silicosis
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Resistance of Human Immunodeficiency Virus Type 1 to a Third-Generation Fusion Inhibitor Requires Multiple Mutations in gp41 and Is Accompanied by a Dramatic Loss of gp41 Function
2011
Reverse Transcriptase (RT) Inhibition of PCR at Low Concentrations of Template and Its Implications for Quantitative RT-PCR
1998
PCR inhibitors - occurrence, properties and removal
2012 Standout
Abacavir and Mycophenolic Acid, an Inhibitor of Inosine Monophosphate Dehydrogenase, Have Profound and Synergistic Anti-HIV Activity
1999
Varicella-zoster virus
1996 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Electrochemiluminescence (ECL)
2004 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Exchange blood transfusion in severe falciparum malaria: retrospective evaluation of 61 patients treated with, compared to 63 patients treated without, exchange transfusion
1997
Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR
1999
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
Targeting and Penetration of Virus Receptor Bearing Cells by Nanoparticles Coated with Envelope Proteins of Moloney Murine Leukemia Virus
2006
Prosthetic Joint Infection
2014 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Silicoproteinosis: High-Resolution CT Findings in 13 Patients
2007
Abacavir and Mycophenolic Acid, an Inhibitor of Inosine Monophosphate Dehydrogenase, Have Profound and Synergistic Anti-HIV Activity
1999
Hematological Problems in Pediatric Intensive Care
2013 Standout
Red Blood Cell Exchange Transfusion as an Adjunct Treatment for Severe Pediatric Falciparum Malaria, Using Automated or Manual Procedures
2005
Works of F. Biron being referenced
Vaccination contre la grippe : résultats d'une enquête sur la couverture vaccinale du personnel hospitalier à l'hôpital de la Croix-Rousse (hôpitaux de Lyon)
2006
Severe falciparum malaria (21 cases)
1991
Possibly Linezolid-Induced Peripheral and Central Neurotoxicity: Report of Four Cases
2005
Measurement by the polymerase chain reaction of the Epstein‐Barr virus load in infectious mononucleosis and AIDS‐related non‐Hodgkin's lymphomas
1995
Long-Term Safety and Antiretroviral Activity of Hydroxyurea and Didanosine in HIV-Infected Patients
2000
Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals
1996
Acute Silicosis Due to Inhalation of a Domestic Product
1991
Les ostéomyélites du pubis de l’athlète
2001
Secretory IgA Antibodies to Cryptosporidium parvum in AIDS patients with Chronic Cryptosporidiosis
1994
Anti-HIV Activity of the Combination of Didanosine and Hydroxyurea in HIV-1-Infected Individuals
1995
[Severe pulmonary varicella in 7 non-immunodepressed adults].
1988
Evolutionary Dynamics of the Glycan Shield of theHuman Immunodeficiency Virus Envelope during Natural Infection andImplications for Exposure of the 2G12Epitope
2004
Matrix and Envelope Coevolution Revealed in a Patient Monitored since Primary Infection with Human Immunodeficiency Virus Type 1
2009